Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia
Condition: Colorectal Cancer · Colorectal Neoplasms · Colorectal Adenoma · Sponsor: Chinese University of Hong Kong
About this study
The investigators aim to evaluate and compare the diagnostic accuracy of FIT and the novel panel of bacterial gene markers (Fn, m3, Ch and Bc) collectively named as M3, in detecting colorectal advanced neoplasia.
This description comes directly from the study's public registry record.
Talk to the study team
Connie Seto · 6049 0760 · waiyiseto@cuhk.edu.hk
Min Dai · 6049 0760 · mindai@link.cuhk.hk
Always discuss trial participation with your own doctor first.
Locations (1)
| Prince of Wales Hospital | Hong Kong, Hong Kong | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05405673